The family of a woman who died from excessive bleeding filed a wrongful death lawsuit against the makers of Pradaxa, claiming that the drug had led to the patient’s death. Recently, a federal jury in West Virginia agreed with the family’s claims. The jury ordered... Read More

A watchdog group has questioned the FDA’s approval process of the blood-thinning medication Pradaxa, noting numerous deaths and lawsuits that have occurred since the drug went on the market. After a detailed review of the approval of this drug, the FDA has been described as... Read More

A recent analysis published in JAMA Internal Medicine shows that 10 percent of cases where a drug causes severe harm to patients are not reported to the FDA within the specified 15-day time period. This lag time in reporting serious adverse events endangers lives needlessly,... Read More

According to a new report, an investigation by the British Medical Journal suggests that manufacturer Boehringer Ingelheim withheld evidence of Pradaxa bleeding events from government regulators. Without access to the undisclosed drug risk information, the Federal Drug Administration (FDA) and foreign regulators approved the use... Read More

After issuing a temporary stay in the litigation between drug maker Boehringer Ingelheim and 4,000 injured plaintiffs, a Pradaxa settlement has been reached for a reported $650 million. Just one day before, U.S. District Judge David R. Herndon of the Southern District of Illinois convened... Read More

In an FDA drug safety communication published on May 13, the agency warned of an increased stomach bleeding risk with Pradaxa compared to its competitor, warfarin. Both anticoagulant medications are used to reduce the chance of stroke in patients with non-valvular atrial fibrillation, but recent... Read More

With the Pradaxa multidistrict litigation (MDL) reaching critical stages in the coming months, the pace of developments in the cases pending under the auspices of Judge David R. Herndon in the U.S. District Court for the Southern District of Illinois shows no signs of abating.... Read More

As Pradaxa lawsuits continue to mount, some of the plaintiffs filing complaints are attempting to hold additional parties accountable for injuries related to the anticoagulant drug. Nearly all the plaintiffs filing complaints are naming Boehringer Ingelheim as the primary defendant. However, The Spectator reports that... Read More